GIMRA PUTS APTYS PHARMA IN THE SPOTLIGHT
François Boutignon, APTYS PHARMA’s President exposes news and activities of Biotech partner since 2002.Read more
🚀 Metapain® is on his way on Phase III!
We are pleased to announce that the Metapain® study has enrolled its first patient in Russia, reaching a total of …Read more
Bernard van Iseghem, Aptys Pharma’s Managing Director
Biotech Finances talks about Aptys Pharma !Read more
Our new Head of Analytical R&D
After 12 years working as analyst then as Analytical project manager, Yannick Barrier becomes now the new Head of analytical …Read more